THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: QHF5ZZ114M72
37contracts won
$31,510,325total obligated
$520,616median contract
Sep 30, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 31 | $28,862,340 |
| National Aeronautics and Space Administration | 1 | $2,000,000 |
| Department of Defense | 1 | $359,900 |
| Department of State | 4 | $288,084 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 13 | $16,642,496 |
| 611710 Educational Support Services | 2 | $3,740,535 |
| 541512 Computer Systems Design Services | 1 | $2,501,040 |
| 541720 Research and Development in the Social Sciences and Humanities | 2 | $2,452,605 |
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 7 | $2,250,268 |
| 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) | 2 | $1,165,832 |
| 622110 General Medical and Surgical Hospitals | 2 | $992,335 |
| 621399 Offices of All Other Miscellaneous Health Practitioners | 1 | $730,877 |
| 325413 In-Vitro Diagnostic Substance Manufacturing | 1 | $637,675 |
| 541380 Testing Laboratories and Services | 4 | $338,663 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS)
75N98026F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$763,760 Potential value: $5,857,260 |
Sep 30, 2026 Ends: Sep 29, 2027 |
| RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) REGIONAL HUBS
75N98026F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$829,129 Potential value: $6,441,138 |
Sep 30, 2026 Ends: Sep 29, 2027 |
| HANOINAMRU-IP_REACTIONS SET AND CORRESPONDING TWIST REAGENTS
19VM3026P0564 · NAICS 541380 Testing Laboratories and Services |
— | Department of State | $40,000 | Aug 14, 2026 Ends: Nov 29, 2026 |
| ASSAY-SPECIFIC REAGENTS AND PROPRIETARY PRIMER/PROBE MATERIALS REQUIRED TO PERFORM THE COLUMBIA/GAPP VIRCAPSEQ WORKFLOW AT WRAIR-AFRIMS, BAN…
19GE5026P0062 · NAICS 334516 Analytical Laboratory Instrument Manufacturing |
— | Department of State | $29,000 | Aug 11, 2026 Ends: Sep 10, 2026 |
| WRAIR_GAPP PACKAGE A
19GG8026P0361 · NAICS 621511 Medical Laboratories · New York, NY |
— | Department of State | $29,000 | Jul 17, 2026 Ends: Aug 30, 2026 |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A
75N92026F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Bethesda, MD |
— | Department of Health and Human Services National Institutes of Health |
$437,119 Potential value: $4,146,882 |
Feb 13, 2026 Ends: Dec 18, 2026 |
| NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVE…
75N94025F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$539,573 Potential value: $655,907 |
Sep 29, 2025 Ends: Dec 31, 2027 |
| HANOINAMRU-IP_VIRCAPSEQ-VERT PROBE SET AND TWIST REAGENTS
19VM3025P0594 · NAICS 541380 Testing Laboratories and Services |
— | Department of State | $190,084 | Jul 27, 2025 Ends: Sep 29, 2025 |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS
75N92025F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Rockville, MD |
— | Department of Health and Human Services National Institutes of Health |
$186,106 | Dec 19, 2024 Ends: Mar 07, 2025 |
| CISA RSV INFANTS STUDY (CONTRIBUTING SITE)
75D30124F00002 · NAICS 622110 General Medical and Surgical Hospitals · Durham, NC |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$767,661 Potential value: $774,425 |
Sep 27, 2024 Ends: Sep 26, 2027 |
| (BEST) INITIATIVE: COMMUNITY ENGAGEMENT AND DEVELOPMENT INITIATIVE FOR A CONVENER ORGANIZATION TO PROVIDE THE FDA WITH SUPPORT TO COLLABORAT…
75F40124F19003 · NAICS 611710 Educational Support Services · New York, NY |
— | Department of Health and Human Services Food and Drug Administration |
$172,546 | Sep 26, 2024 Ends: Mar 07, 2025 |
| CSO - AUTOMATED SOLUTION FOR COLD CULTIVATION CULTUROMICS U437N00
W913E524C0028 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · New York, NY |
— | Department of Defense Department of the Army |
$359,900 | Sep 26, 2024 Ends: Mar 07, 2025 |
| CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP
75F40124C00081 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · New York, NY |
— | Department of Health and Human Services Food and Drug Administration |
$237,268 | Sep 16, 2024 Ends: Mar 07, 2025 |
| TBDC CAPSEQ-TRANCRIPTOME ANALYSIS SERVICE
75N93024P01130 · NAICS 541380 Testing Laboratories and Services · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$41,250 | Sep 16, 2024 Ends: Sep 15, 2025 |
| BAAFDA-24-00123, REFERENCE FY24C3DP2: SYSTEMATIC REVIEW OF NEURODEVELOPMENTAL OUTCOME IN VULNERABLE PEDIATRIC PATIENT POPULATIONS
75F40124C00087 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · New York, NY |
— | Department of Health and Human Services Food and Drug Administration |
$48,448 | Aug 15, 2024 Ends: Mar 07, 2025 |
| REDS-IV-P DOMESTIC HUBS
75N92024F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$1,656,603 | Jul 01, 2024 Ends: Mar 07, 2025 |
| PROSPECTIVE LONG-TERM FOLLOW-UP OF COVID 19 INFECTION WITH NEUROLOGICAL MANIFESTATIONS
75D30124P18698 · NAICS 541720 Research and Development in the Social Sciences and Humanities · Atlanta, GA |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$249,000 | Apr 24, 2024 Ends: Jun 30, 2025 |
| A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
75N93023C00041 · NAICS 541512 Computer Systems Design Services · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$2,501,040 | Sep 30, 2023 Ends: Mar 07, 2025 |
| 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
75D30123F00001 · NAICS 622110 General Medical and Surgical Hospitals · New York, NY |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$224,674 Potential value: $300,905 |
Sep 28, 2023 Ends: Sep 27, 2027 |
| OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVI…
75N94023F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$87,270 | Sep 28, 2023 Ends: Mar 28, 2025 |
| IN VIVO TESTING OF A LEAD COQ10 BIOSYNTHESIS INHIBITOR IN AN SK-BR-3 XENOGRAPH MOUSE MODEL
75N95023P00861 · NAICS 541380 Testing Laboratories and Services · New York, NY |
— | Department of Health and Human Services National Institutes of Health |
$67,329 Potential value: $71,964 |
Sep 26, 2023 Ends: Nov 06, 2024 |
| THE OBJECTIVES OF THE PROPOSED STUDY ARE TO EXAMINE THE EFFECTS OF POSTNATAL MANAGEMENT APPROACHES (NON-PHARMACOLOGICAL, INCLUDING ESC VERSU…
75F40123C00211 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD |
— | Department of Health and Human Services Food and Drug Administration |
$520,616 | Sep 25, 2023 Ends: Jun 27, 2025 |
| LAMP STUDY
75D30123C17500 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Brookhaven, GA |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$91,531 | Aug 24, 2023 Ends: Aug 07, 2024 |
| CONTRACT FOR RESEARCH AND DEVELOPMENT WORK TO EXTENDED LONGEVITY OF 3D TISSUES AND MICROPHYSIOLOGICAL SYSTEMS FOR MODELING OF ACUTE AND CHRO…
80ARC023CA004 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Stanford, CA |
— | National Aeronautics and Space Administration | $2,000,000 | Nov 01, 2022 Ends: Mar 07, 2025 |
| PEDIATRIC COVID-19 VACCINATION RCT
75D30122F00007 · NAICS 621399 Offices of All Other Miscellaneous Health Practitioners · New York, NY |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$730,877 | Sep 29, 2022 Ends: Dec 28, 2025 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.